Prof. Zelber Sagi

Pr Zelber Sagi explains there is an option for life's treatment at each stage of non-alcoholic fatty liver disease NAFLD with lifestyle examples in clinical practice.

Currently, there are no Food and Drug Administration (FDA)-approved or European Medicines Agency (EMA)-approved therapies for NASH and only lifestyles interventions are recommended for the treatment of NAFLD. Prof Zelber-Sagi (Haifa, Israel) reviews best practices for lifestyle interventions in patients with NAFLD. She warns us against ultra-processed foods and drinks, that are so common in the Western world. She also highlights the benefits of the Mediterranean diet and physical activity.